Calculation of residence times and radiation doses using the standard PC software Excel
- PMID: 9391187
- DOI: 10.1007/s002590050182
Calculation of residence times and radiation doses using the standard PC software Excel
Abstract
We developed a program which aims to facilitate the calculation of radiation doses to single organs and the whole body. IMEDOSE uses Excel to include calculations, graphical displays, and interactions with the user in a single general-purpose PC software tool. To start the procedure the input data are copied into a spreadsheet. They must represent percentage uptake values of several organs derived from measurements in animals or humans. To extrapolate these data up to seven half-lives of the radionuclide, fitting to one or two exponentional functions is included and can be checked by the user. By means of the approximate time-activity information the cumulated activity or residence times are calculated. Finally these data are combined with the absorbed fraction doses (S-values) given by MIRD pamphlet No. 11 to yield radiation doses, the effective dose equivalent and the effective dose. These results are presented in a final table. Interactions are realized with push-buttons and drop-down menus. Calculations use the Visual Basic tool of Excel. In order to test our program, biodistribution data of fluorine-18 fluorodeoxyglucose were taken from the literature (Meija et al., J Nucl Med 1991; 32:699-706). For a 70-kg adult the resulting radiation doses of all target organs listed in MIRD 11 were different from the ICRP 53 values by 1%+/-18% on the average. When the residence times were introduced into MIRDOSE3 (Stabin, J Nucl Med 1996; 37:538-546) the mean difference between our results and those of MIRDOSE3 was -3%+/-6%. Both outcomes indicate the validity of the present approach.
Similar articles
-
Estimation of absorbed dose for 2-[F-18]fluoro-2-deoxy-D-glucose using whole-body positron emission tomography and magnetic resonance imaging.Eur J Nucl Med. 1998 Jun;25(6):565-74. doi: 10.1007/s002590050257. Eur J Nucl Med. 1998. PMID: 9618570
-
An internal radiation dosimetry computer program, IDAC 2.0, for estimation of patient doses from radiopharmaceuticals.Radiat Prot Dosimetry. 2014 Dec;162(3):299-305. doi: 10.1093/rpd/nct337. Epub 2013 Dec 18. Radiat Prot Dosimetry. 2014. PMID: 24353030
-
Uncertainty Quantification in Internal Dose Calculations for Seven Selected Radiopharmaceuticals.J Nucl Med. 2016 Jan;57(1):122-8. doi: 10.2967/jnumed.115.160713. Epub 2015 Nov 12. J Nucl Med. 2016. PMID: 26564320
-
Radiation doses and risks from internal emitters.J Radiol Prot. 2008 Jun;28(2):137-59. doi: 10.1088/0952-4746/28/2/R01. Epub 2008 May 22. J Radiol Prot. 2008. PMID: 18495991 Review.
-
Biokinetic and dosimetric modelling in the estimation of radiation risks from internal emitters.J Radiol Prot. 2009 Jun;29(2A):A81-A105. doi: 10.1088/0952-4746/29/2A/S06. Epub 2009 May 19. J Radiol Prot. 2009. PMID: 19454809 Review.
Cited by
-
Whole-body distribution and dosimetry of O-(2-[18F]fluoroethyl)-L-tyrosine.Eur J Nucl Med Mol Imaging. 2003 Apr;30(4):519-24. doi: 10.1007/s00259-003-1118-0. Epub 2003 Feb 15. Eur J Nucl Med Mol Imaging. 2003. PMID: 12589478
-
A vaccinia virus encoding the human sodium iodide symporter facilitates long-term image monitoring of virotherapy and targeted radiotherapy of pancreatic cancer.J Nucl Med. 2012 Dec;53(12):1933-42. doi: 10.2967/jnumed.112.105056. Epub 2012 Nov 8. J Nucl Med. 2012. PMID: 23139088 Free PMC article.
-
Biodistribution and radiation dosimetry of the A1 adenosine receptor ligand 18F-CPFPX determined from human whole-body PET.Eur J Nucl Med Mol Imaging. 2008 Aug;35(8):1499-506. doi: 10.1007/s00259-008-0753-x. Epub 2008 Mar 29. Eur J Nucl Med Mol Imaging. 2008. PMID: 18373090
-
Pre-therapeutic dosimetry and biodistribution of 86Y-DOTA-Phe1-Tyr3-octreotide versus 111In-pentetreotide in patients with advanced neuroendocrine tumours.Eur J Nucl Med Mol Imaging. 2004 Oct;31(10):1386-92. doi: 10.1007/s00259-004-1561-6. Epub 2004 Jun 3. Eur J Nucl Med Mol Imaging. 2004. PMID: 15175836 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources